About the Authors
- Kathryn T. Whelan
-
Contributed equally to this work with: Kathryn T. Whelan, Ansar A. Pathan
Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom
- Ansar A. Pathan
-
Contributed equally to this work with: Kathryn T. Whelan, Ansar A. Pathan
Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom
- Clare R. Sander
-
Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom
- Helen A. Fletcher
-
Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom
- Ian Poulton
-
Affiliation Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom
- Nicola C. Alder
-
Affiliation Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom
- Adrian V. S. Hill
-
Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom
- Helen McShane
-
* E-mail: helen.mcshane@ndm.ox.ac.uk
Affiliation Jenner Institute, University of Oxford, Churchill Hospital, Oxford, United Kingdom
Competing Interests
AAP, AVSH and HMcS are all co-inventors on a composition of matter patent for MVA85A and are shareholders in a Joint Venture established to develop this vaccine.
Author Contributions
Conceived and designed the experiments: KTW AVH HM. Performed the experiments: KTW AAP. Analyzed the data: KTW AAP HF NCA HM. Contributed reagents/materials/analysis tools: CRS HF IP. Wrote the paper: KTW HM.